Curia to acquire LakePharma

By The Science Advisory Board staff writers

July 14, 2021 -- Curia, formerly known as Albany Molecular Research (AMRI), has inked a deal to acquire private biologics firm LakePharma.

Once the transaction closes, the combined company will provide expertise in large and small molecules for drug discovery, drug substance manufacturing, sterile injectable formulation, and fill-finish production.

LakePharma has sites in California, Massachusetts, and Texas. Terms of the agreement have not been disclosed.

Curia to acquire Integrity Bio
Curia, formerly known as Albany Molecular Research, has inked a definitive agreement to acquire drug formulation and fill-finish provider Integrity Bio.
AMRI rebrands as Curia
Albany Molecular Research (AMRI) has changed its name to Curia, effective July 12.

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter